The Jackson Laboratory was founded in 1929 by Dr. Clarence Cook Little as a mammalian genetics center with a special focus on the problem of cancer, on the role of genes in both normal and abnormal development and differentiation, and on the development of the requisite genetic tools which could be put to practical use by others in examining these questions. It is the premise of The Jackson Laboratory that basic research directed towards a better understanding of the fundamental mechanisms that control normal and neoplastic growth, differentiation, and development, is essential to understand how cancers originate, develop and metastasize. The investigations pursued by members of the Scientific Staff are interdisciplinary in nature, as is illustrated by the number and diversity of internal and external collaborative projects carried out at the Laboratory. In addition to specific cancer-related research, the basic research carried out by The Jackson Laboratory investigators lays the essential ground work for a better understanding of neoplasia. Organizational capabilities and physical facilities of the Laboratory foster cohesiveness of research effort, and the deliberate avoidance of departmentalization actively promotes interdisciplinary cooperation among Scientific Staff Members. An additional factor contributing to productive research interactions is the widespread use of shared scientific resources and services, especially the genetic resources, as well as shared equipment. The Center Director is also the Director of the Laboratory and reports to the Board of Governing Trustees. The Director controls the total budget, allocates all space and makes all appointments to the Scientific Staff, subject to confirmation by the Board of Governing Trustees. The Jackson Laboratory as a whole has been designated by NCI as a Laboratory Cancer Research Center and with this application seeks continuation of it Cancer Center Support (CORE) Grant. The request is for continuing support for the current components of the grant and for additional support for two new components. CORE support is requested for only 20.6% of the total cost of the Resources and Services involved.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA034196-09
Application #
3101770
Study Section
Cancer Center Support Review Committee (CCS)
Project Start
1983-08-01
Project End
1996-07-31
Budget Start
1991-08-01
Budget End
1992-07-31
Support Year
9
Fiscal Year
1991
Total Cost
Indirect Cost
Name
Jackson Laboratory
Department
Type
DUNS #
042140483
City
Bar Harbor
State
ME
Country
United States
Zip Code
04609
Shi, Jiayuan; Hua, Li; Harmer, Danielle et al. (2018) Cre Driver Mice Targeting Macrophages. Methods Mol Biol 1784:263-275
Sharma, Manju; Braun, Robert E (2018) Cyclical expression of GDNF is required for spermatogonial stem cell homeostasis. Development 145:
Johnson, Kenneth R; Gagnon, Leona H; Tian, Cong et al. (2018) Deletion of a Long-Range Dlx5 Enhancer Disrupts Inner Ear Development in Mice. Genetics 208:1165-1179
Hosur, Vishnu; Farley, Michelle L; Low, Benjamin E et al. (2018) RHBDF2-Regulated Growth Factor Signaling in a Rare Human Disease, Tylosis With Esophageal Cancer: What Can We Learn From Murine Models? Front Genet 9:233
Paigen, Kenneth; Petkov, Petko M (2018) PRDM9 and Its Role in Genetic Recombination. Trends Genet 34:291-300
Dominguez, Pilar M; Ghamlouch, Hussein; Rosikiewicz, Wojciech et al. (2018) TET2 Deficiency Causes Germinal Center Hyperplasia, Impairs Plasma Cell Differentiation, and Promotes B-cell Lymphomagenesis. Cancer Discov 8:1632-1653
Schloss, Jennifer; Ali, Riyasat; Racine, Jeremy J et al. (2018) HLA-B*39:06 Efficiently Mediates Type 1 Diabetes in a Mouse Model Incorporating Reduced Thymic Insulin Expression. J Immunol 200:3353-3363
Nakatsuji, Teruaki; Chen, Tiffany H; Butcher, Anna M et al. (2018) A commensal strain of Staphylococcus epidermidis protects against skin neoplasia. Sci Adv 4:eaao4502
Racine, Jeremy J; Stewart, Isabel; Ratiu, Jeremy et al. (2018) Improved Murine MHC-Deficient HLA Transgenic NOD Mouse Models for Type 1 Diabetes Therapy Development. Diabetes 67:923-935
Ye, Fengdan; Jia, Dongya; Lu, Mingyang et al. (2018) Modularity of the metabolic gene network as a prognostic biomarker for hepatocellular carcinoma. Oncotarget 9:15015-15026

Showing the most recent 10 out of 1156 publications